BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $1.31B
1-Year Est. Return 142.79%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+142.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$971M
AUM Growth
+$171M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$28.8M
2
+$21.7M
3
+$16.3M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$6.44M
5
ANNX icon
Annexon
ANNX
+$3.56M

Top Sells

1
+$23.4M
2
+$19.8M
3
+$17.1M
4
TVRD
Tvardi Therapeutics
TVRD
+$4.86M
5
SYRE icon
Spyre Therapeutics
SYRE
+$1.55M

Sector Composition

1 Healthcare 98.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$6.69M 0.69%
2,124,694
27
$6.38M 0.66%
1,921,790
28
$4.52M 0.47%
1,642,210
29
$3.08M 0.32%
640,631
30
$2.65M 0.27%
25,969
-35,266
31
$2.03M 0.21%
1,937,207
32
$209K 0.02%
100,000
33
– –
-213,908
34
– –
-8,891,758
35
– –
-4,702,996
1
2